Interestingly, high Ki-67 expression in breast cancer tissue was also a significant predictive factor for the response to neoadjuvant chemotherapy, especially in ER-negative and HER2-positive breast cancer patients42. This evidence concerns the gene ERBB2 and breast carcinoma.